The 2026 landscape for the Generic Drugs Market is defined by an unprecedented "Patent Cliff." As of early 2026, the global market is valued at approximately $445.32 billion, with experts forecasting that patent expiries scheduled between 2026 and 2028 will release nearly $40 billion in annual branded revenue. This 2026 surge is creating a gold rush for generic manufacturers who are racing to...